Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.

Journal of Alzheimer's disease : JAD - 1 Jan 2017

Lusardi Theresa A, Phillips Jay I, Wiedrick Jack T, Harrington Christina A, Lind Babett, Lapidus Jodi A, Quinn Joseph F, Saugstad Julie A

Abstract excerpt

BACKGROUND: Currently available biomarkers of Alzheimer's disease (AD) include cerebrospinal fluid (CSF) protein analysis and amyloid PET imaging, each of which has limitations. The discovery of extracellular microRNAs (miRNAs) in CSF raises the possibility that miRNA may serve as novel biomarkers of AD. OBJECTIVE: Investigate miRNAs in CSF obtained from living donors as biomarkers for AD. METHODS: We profiled...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein E4

Share to Logistic Models

Share to Mental Status Schedule

Share to MicroRNAs

Share to Positron-Emission Tomography

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 27814298
DOI: 10.3233/JAD-160835
PMCID: PMC5587208

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.PMID 27814298Read ↗

Validation of MicroRNA Biomarkers for Alzheimer’s Disease in Human Cerebrospinal FluidSemantic proximity Read ↗

MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseaseSemantic proximity Read ↗

Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer’s DiseaseSemantic proximity Read ↗

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)Semantic proximity Read ↗

Plasma microRNAs as potential biomarkers in early Alzheimer disease expressionSemantic proximity Read ↗

Cerebrospinal fluid CD4+ T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer's disease biomarkersSemantic proximity Read ↗

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s DiseaseSemantic proximity Read ↗

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer diseaseSemantic proximity Read ↗

A blood based 12-miRNA signature of Alzheimer disease patientsSemantic proximity Read ↗

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseasesSemantic proximity Read ↗

Literature-Identified Serum miRNA Signatures for Cognitive Decline: Integrated Analysis and Machine-Learning Diagnostics in Alzheimer’s DiseaseSemantic proximity Read ↗

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic BiomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.